# Major Recall Alert: Teve 5-ASA Tablet (aka MESALAMINE) Recalled Due to Dissolution Stability Test Issue
## Why This Recall is Important
Canadian consumers should be aware of a significant recall affecting Teva Canada's **Teve 5-ASA tablet (also known as MESALAMINE)**. This widely used medication is primarily prescribed to treat inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease. However, an issue has been detected in specific lots of the product where the **dissolution stability tests were found to be out of specification.**
This issue could potentially impact the effectiveness of the medication, making it unable to provide the therapeutic benefits patients rely on. If left unchecked, this problem could lead to adverse health effects, including worsening symptoms of inflammatory conditions.
Health Canada has issued a formal recall to safeguard public health. It is crucial for consumers and healthcare professionals to act promptly by identifying the affected products and following the appropriate safety measures.
## Details of the Recall
Teva Canada has issued a recall for the **Teve 5-ASA tablet (MESALAMINE)** due to inconsistencies in the dissolution stability tests for certain lots. Here’s what you need to know:
- **Brand**: Teva Canada
- **Product Name**: Teve 5-ASA Tablet (also called MESALAMINE)
- **Category**: CAN – Dissolution stability test out of specification
- **Reason for Recall**: Testing showed that the medication did not meet required stability standards, potentially compromising its ability to dissolve properly and deliver active ingredients effectively.
- **Date of Recall Announcement**: October 2023
- **Affected Lots**: Refer to the [official Health Canada recall notice](https://recalls-rappels.canada.ca/en/alert-recall/teve-5-asa-tablet-aka-mesalamine-out-specification-stability-dissolution) for detailed lot numbers and further information.
Teva Canada is taking proactive measures to ensure consumer safety by recalling all impacted products from the shelves and encouraging affected customers to return them immediately.
## What You Should Do
If you are currently using Teve 5-ASA (MESALAMINE) tablets, it’s essential to take the following steps:
1. **Check for Affected Lot Numbers**: Compare the lot numbers of your medication with those listed in the [official recall alert](https://recalls-rappels.canada.ca/en/alert-recall/teve-5-asa-tablet-aka-mesalamine-out-specification-stability-dissolution).
2. **Stop Using the Medication**: If your product is part of the recall, discontinue use immediately.
3. **Contact Your Healthcare Provider**: Speak with your doctor or pharmacist about alternative treatment options or to determine if your health has been impacted.
4. **Return the Product**: Bring the affected medication to your pharmacy or point of purchase for proper disposal. Consumers can contact Teva Canada for assistance if needed.
It's vital to follow these guidelines to prevent any potential health complications associated with using recalled products.
## Stay Safe – Get Instant Recall Alerts
Product recalls like this emphasize the importance of staying informed about potential health risks. Don’t be caught off guard—take charge of your safety with instant recall notifications.
### Download Our Free App Today
Stay ahead of recalls and product alerts by downloading our user-friendly app. Get real-time updates for food, health, and product recalls that matter to you and your family. Protect your health with just one tap!
Click here to download and start safeguarding yourself: **[Download Now]**
For more information on this specific recall, visit the [Health Canada official website](https://recalls-rappels.canada.ca/en/alert-recall/teve-5-asa-tablet-aka-mesalamine-out-specification-stability-dissolution).
---
By taking the right steps and staying alert, Canadians can ensure their medication remains safe and effective. Be informed, act quickly, and protect your health today!